Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Andreas Seeber"'
Autor:
Dominik Wolf, Andreas Seeber, Katharina Kurz, Florian Kocher, Arno Amann, Kai Zimmer, Andreas Pircher, Simon Geisler, Dietmar Fuchs, Renate Pichler
Publikováno v:
Transl Lung Cancer Res
Background Metabolic profiling in non-small cell lung cancer (NSCLC) may identify key metabolic vulnerabilities and shows enormous discovery potential. Preclinical studies showed that metabolic rewiring in cancer plays an essential role in modulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5923d44bf0b8893b1c0b7a7f06a07d
https://europepmc.org/articles/PMC7867793/
https://europepmc.org/articles/PMC7867793/
Publikováno v:
Oncology Research and Treatment. 41:188-193
Angiogenesis is a hallmark of cancer and is regulated by a balance of pro- and anti-angiogenic factors; among them, the vascular endothelial growth factor (VEGF) is the key angiogenic factor. VEGF plays an important role in colorectal cancer (CRC) bi
Autor:
Dario Trapani, Wolfgang Willenbacher, Gilbert Spizzo, Sara Cecilia Altuna Mujica, Andreas Seeber, Shahzeb Khan, Dominik Wolf, Ella Willenbacher, Sadaqat Hussain
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 8, p 1808 (2019)
International Journal of Molecular Sciences, Vol 20, Iss 8, p 1808 (2019)
Cancer patients frequently use complementary medicine. Curcumin (CUR) and its derivates (from the extract of Curcuma longa L.) represent some of the most frequently used ones, having a long history in traditional Asian medicine. CUR was demonstrated,
Autor:
Sadaqat Hussain, Dario Trapani, Dominik Wolf, Sara Cecilia Altuna Mujica, Shahzeb Khan, Ella Willenbacher, Gilbert Spizzo, Andreas Seeber, Wolfgang Willenbacher
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 5725, p 5725 (2020)
We would like to change the authors’ names and affiliations on Page 1 of paper [...]
Autor:
Andreas Seeber, Luigi Terracciano, Alessandro Lugli, Florian Kocher, Gerold Untergasser, Armin Kasal, Guido Mazzoleni, Gilbert Spizzo, Normann Steiner, Dominic Fong, Guenther Gastl
Publikováno v:
International Journal of Cancer. 139:657-663
Regulated intramembrane proteolysis (RIP) has been shown to be an important mechanism for oncogenic activation of EpCAM through nuclear translocation of the intracellular domain EpICD. Recently, we identified two different membranous EpCAM variants n
Autor:
Andreas Seeber, Günther Gastl
Publikováno v:
Oncology Research and Treatment. 39:796-802
Over the past decades, considerable progress has been made in the management of colorectal cancer (CRC), leading to a significant improvement in overall survival. Although part of this success has been rightly attributed to aggressive surgical manage
Publikováno v:
Stem Cells Translational Medicine
Colorectal cancer (CRC) is one of the most common malignancies worldwide. In spite of various attempts to ameliorate outcome by escalating treatment, significant improvement is lacking particularly in the adjuvant setting. It has been proposed that c
Autor:
Jalid Sehouli, Guenther Gastl, Dominic Fong, Laura Botta, Andreas Seeber, Gilbert Spizzo, Alain G. Zeimet, Mani Nassir, Gerold Untergasser, Heidi Fiegl, Ioana Braicu
Publikováno v:
Oncotarget
EpCAM is an attractive target for cancer therapy and the EpCAM-specific antibody catumaxomab has been used for intraperitoneal treatment of EpCAM-positive cancer patients with malignant ascites. New prognostic markers are necessary to select patients
Autor:
Kathrin Philipp-Abbrederis, Christoph Leitner, Gilbert Spizzo, Andreas Seeber, Florian Kocher
Publikováno v:
Future oncology (London, England). 13(16)
Systemic therapy options for small cell lung cancer patients with extensive disease remain poor. After an initial response on first-line therapy, virtually all patients develop disease progression. For those who showed an initial response only few th
Autor:
Gilbert Spizzo, Guido Mazzoleni, Dominic Fong, Peter Obrist, Armin Kasal, Patrizia Moser, Martin Wurm, Christine Mian, Andreas Seeber, Agnieszka Martowicz, Guenther Gastl
Publikováno v:
Histopathology. 64:683-692
Aims Epithelial cell adhesion molecule (EpCAM) is a widely used immunohistochemical marker for epithelial human malignancies. Antibodies to target EpCAM are usually directed against its ectodomain (EpEX), but do not detect the intracellular domain (E